Evidence map›Paper›PMID 25756992›Full record

ArticlePloS one2015

Characterization of methicillin-resistant and -susceptible staphylococcal isolates from bovine milk in northwestern china.

Longping Li, Luoxiong Zhou, Lihong Wang, Huping Xue, Xin Zhao

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Molecular epidemiology and characterization of antimicrobial-resistantFrontiers in cellular and infection microbiology · 2023
    Article
  5. Antimicrobial resistance and genetic diversity ofOne health (Amsterdam, Netherlands) · 2022
    Article
  6. Article
  7. Article
  8. Antibiotics Resistance and Virulence ofFoods (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Prevalence and Characteristics ofFrontiers in microbiology · 2021
    Article
  14. Article
  15. Risk Factors for the Occurrence of Methicillin-ResistantFoodborne pathogens and disease · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Colistin InducesFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Longping LiCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Luoxiong ZhouCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Lihong WangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Huping XueCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Xin ZhaoCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China; Department of Animal Science, McGill University, 21,111 Lakeshore, Ste. Anne de Bellevue, Quebec, H9X 3V9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emergence of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MR-CoNS) in bovine milk is a major public health concern. The primary purpose of this research was to determine molecular genetic characteristics and antibiotic resistance of staphylococcal isolates recovered from milk of mastitic cows in the Shaanxi Province in Northwestern China. One hundred and thirteen methicillin-susceptible Staphylococcus aureus (MSSA), one mecA-positive and phenotype-positive MRSA, seven mecA- and mecC- negative but phenotype-positive MRSA and two MR-CoNS including one oxacillin-susceptible mecA-positive Staphylococcus haemolyticus (OS-MRSH) and one mecA-positive and methicillin-resistant Staphylococcus epidermidis (MRSE) isolates were recovered from 214 quarter milk samples on 4 dairy farms. All above 123 isolates were subjected to antibiotic resistance profiling. S. aureus isolates were also genotyped using the spa typing and the multilocus sequence typing (MLST). Eight MRSA and 2 MR-CoNS isolates were additionally tested for SCCmec types. Resistance was common among isolates against ampicillin or penicillin (80.5%), kanamycin (68.3%), gentamicin (67.5%), tetracycline (43.9%) and chloramphenicol (30.1%). However, no isolate was resistant to vancomycin or teicoplanin. Twenty, 29 and 58 isolates showed resistance to 1, 2 or more than 2 antibiotics, respectively. The predominant multidrug resistance profile was penicillin/ampicillin/kanamycin/gentamicin/tetracycline (46 isolates). Most S. aureus isolates belonged to spa types t524 (n = 63), t11772 (a new type, n = 31) and t4207 (n = 15). At the same time, MLST types ST71 (n = 67) and ST2738 (a new type, n = 45) were identified as dominant sequence types. The mecA-positive and phenotype-positive MRSA isolate had a composite genotype t524-ST71-SCCmecIVa, while 7 mecA-negative but phenotype-positive MRSA isolates were all t524-ST71. The OS-MRSH isolate contained a type V SCCmec cassette, while the MRSE isolate possessed a non-typeable SCCmec. The spa-MLST types t11772-ST2738 (n = 27), t11807-ST2683 (n = 4) and t11771-ST2738 (n = 3) were newly identified genotypes of S. aureus. These new genotypes and multidrug-resistant staphylococci could pose additional threat to animal and human health.

Indexed as

AnimalsBacterial Typing TechniquesCattleChinaDNA, BacterialDrug Resistance, Multiple, BacterialGenotypeMethicillinMethicillin ResistanceMilkMultilocus Sequence TypingStaphylococcusDNA, BacterialMethicillin

Identifiers

PMID25756992
PMCPMC4355487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.